The role of p27kipl protein expression on the biological behavior of intrahepatic cholangiocarcinoma

Hepatology

Volumn 33, Issue 5, 2001, Pages 1118-1123

  Taguchi, Ken Ichi ^a   Aishima, Shin Ichi ^a   Asayama, Yoshiki ^a   Kajiyama, Kiyoshi ^a   Kinukawa, Naoko ^a   Shimada, Mitsuo ^a   Sugimachi, Keizo ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN; PROTEIN P27;

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; FEMALE; HUMAN; INTRAHEPATIC BILE DUCT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL; ADULT; AGED; CANCER INVASION; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER RESECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL CYCLE PROTEINS; CHOLANGIOCARCINOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0034744429     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.24028     Document Type: Article

References (40)

1. Diagnosis and treatment of cholangiocellular carcinoma of the liver
2. Prognostic factors of resectable intrahepatic cholangiocarcinoma
3. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?
4. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma. A special reference of 'Scirrhous-type' and 'nonscirrhous-type' growth
5. Inhibitors of mammalian G1 cyclin-dependent kinases
6. GI control in mammalian cells
7. Cyclins, cyclin-dependent kinases, and CDK inhibitors: Implications in cell cycle control and cancer
8. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas
9. Expression of cell-cycle regulators, p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
10. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
11. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers
12. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
13. Localization and expression of p27kip1 in multistage colorectal carcinogenesis
14. p27 expression and gastric carcinoma
15. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma
16. Low p27 expression predicts poor disease-free survival in patients with prostate cancer
17. Expression of p27kip1 in prostatic adenocarcinoma
18. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
19. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma
20. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
21. Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer
22. p27KIP1 in human lung cancers: Differential changes in small cell and non-small cell carcinomas
23. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: Inverse correlation with disease-free survival
24. Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity
25. Aberrant p27kip1 expression in endocrine and other tumors
26. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors
27. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries
28. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours
29. Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index
30. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor
31. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence
32. Intrahepatic cholangiocarcinoma. Results of aggressive surgical management
33. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors
34. Outcomes after curative resections of cholangiocarcinoma
35. Liver resection for bile duct cancer
36. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma
37. Prognostic significance of p27kip1 expression in colorectal cancer: A clinicopathological characterization
38. Translational control of p27Kip1 accumulation during the cell cycle
39. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
40. Degradation of the cyclin-dependent-kinase inhibitor p27kip1 is instigated by Jab 1